I-3-(Hydroxymethyl)phenylboronic Acid CAS 87199-15-3 Purity >99.5% (HPLC) Factory High Quality
Ukuhlinzeka Ngomkhiqizi Ngekhwalithi Ephezulu, Ukukhiqiza Kwezentengiso
Igama Lekhemikhali: 3-(Hydroxymethyl)phenylboronic Acid
I-CAS: 87199-15-3
Igama Lekhemikhali | 3-(Hydroxymethyl)phenylboronic Acid |
Omqondofana | 3-(Hydroxymethyl)benzeneboronic Acid |
Inombolo ye-CAS | 87199-15-3 |
Inombolo yeCAT | I-RF-PI1296 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifika Kumathani angama-25/ngenyanga |
I-Molecular Formula | C7H9BO3 |
Isisindo samangqamuzana | 151.96 |
I-Melting Point | 95.0~99.0℃ (okhanyisiwe) |
Ukuncibilika | I-Soluble ku-Methanol;Incibilika Kancane Emanzini |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Impushana Emhlophe Kuya Kumhlophe |
Ukuhlanzeka / Indlela Yokuhlaziya | >99.5% (HPLC) |
Ukulahlekelwa Ekumisweni | <0.50% |
Izinsalela Ekushiseni | ≤0.20% |
Ukungcola Okukodwa | <0.20% |
Ukungcola Okuphelele | <0.50% |
Izinsimbi Ezisindayo (njenge-Pb) | <20ppm |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | Pharmaceutical Intermediates |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.
![1](https://www.ruifuchemical.com/uploads/15.jpg)
![](https://www.ruifuchemical.com/uploads/23.jpg)
I-3-(Hydroxymethyl)phenylboronic Acid (CAS: 87199-15-3), I-Reactant esetshenziselwa i-Suzuki-Miyaura Cross Coupling Reaction, i-copper-mediated trifluoromethylation, ukuguqulwa kwe-copper-catalyzed kusuka ku-arylboronic acid emanzini, i-Mitsunobu, i-Suzukis ne-amidation reaction. i-hydroxyphenylamino bromopyrazinecarboxylate.I-Reactant ehilelekile ekuhlanganiseni kwama-molecule aphilayo ahlanganisa i-Mycobacterium tuberculosis H37Rv chorismate mutase inhibitors nge-Suzuki coupling reactions, ama-HIV protease inhibitors anomsebenzi wokulwa namagciwane ngokumelene namagciwane amelana nemithi, okuphuma ku-Pyrrole okusetshenziselwa njenge-PDE4B inhibitors.